The Restless Legs Syndrome Foundation updates its algorithm for the management of RLS. The most notable change is a firm pivot away from dopamine agonist medications as first-line treatments.
Read More
The sleep intervention is conducted using the digital app platform, providing people with personalized sleep treatment plans, contextual nudges, sleep management tools, and a clinically validated sleep assessment.
Read More
The FDA approval of QUVIVIQ is based on a phase 3 clinical program that demonstrated improvement versus placebo on objective measures of sleep onset and sleep maintenance, as well as patient-reported total sleep time.
Read More
An authoritative and comprehensive guide to the practice of sleep medicine, the latest edition of the book the Principles and Practice of Sleep Medicine, is now available for purchase.
Read More
Finnish tech company QuietOn announced it will be showcasing QuietOn 3, the company’s latest technology to optimize sleep, this week at CES 2022.
Read More